Background: Mounting experimental evidence supports the concept that the RAAS (renin-
angiotensin-aldosterone system) is involved in the pathogenesis of intracranial aneurysm …

Background: Adverse drug reactions (ADRs) related to angiotensin-converting enzyme
inhibitor (ACEI) and angiotensin receptor blocker (ARB) may negatively affect patients' …

Frank Lederle and Brent Taylor focus on our sensitivity analysis, which showed an
increased risk of rupture in patients who discontinue angiotensin-converting-enzyme (ACE) …

Objective To investigate whether there is an association between use of ACE inhibitors
(ACEI) and angiotensin receptor blockers (ARB) and risk of acute kidney injury (AKI). Study …

Background The results of previous studies reporting the epidemiology of ruptured
abdominal aortic aneurysm (RAAA) are highly heterogeneous. Furthermore, although RAAA …

found that use of an angiotensin-converting-enzyme (ACE) inhibitor in the past year,
including the past 3 months, was negatively associated with admission for ruptured …

Background: Endovascular abdominal aortic aneurysm repair (EVAR) is the major treatment
for abdominal aortic aneurysm (AAA); however, EVAR still carries a considerable risk of …

Background Perioperative mortality is low for patients undergoing abdominal aortic
aneurysm (AAA) repair, but long-term survival remains poor. Although patients diagnosed …

Background Aim of this study was to analyze hospital incidence, type of treatment, and
hospital mortality rates of patients with abdominal aortic aneurysm (AAA) in Germany from …

Objectives It is unknown whether preoperative use of ACE inhibitors (ACE-I) or angiotensin
receptor blockers (ARBs) affects the risk of acute kidney injury (AKI) after colorectal cancer …